Loan demand and board exits hit Splash Beverage (NYSE: SBEV)
Rhea-AI Filing Summary
Splash Beverage Group, Inc. amended settlement agreements with three prior investors, extending payment of remaining settlement amounts of $535,595 to June 1, 2026, with 12% interest and investor attorneys’ fees, and committing to additional installments totaling $100,000 by May 15, 2026.
Board members Justin Yorke and Robert Nistico resigned, and Nistico entered a six‑month consulting agreement at $5,000 per month plus a stock option for 250,000 shares subject to vesting tied in part to a potential Medterra CBD, LLC acquisition. The company also received a demand letter from Decathlon Alpha IV, L.P. seeking immediate payment of obligations under a revenue loan agreement totaling $2,833,395.98 as of March 31, 2026, secured by the assets of Splash Beverage and its subsidiaries, which the company disputes.
Positive
- None.
Negative
- Disputed secured loan demand of $2.83M: Decathlon Alpha IV, L.P. delivered a demand letter seeking immediate payment of obligations totaling $2,833,395.98 as of March 31, 2026 under a revenue loan secured by the company’s and subsidiaries’ assets, following earlier default notices.
- Costly extension of settlement obligations: Remaining settlement payments of $535,595 were deferred to June 1, 2026 at a 12% interest rate plus attorneys’ fees, indicating additional financial burden alongside required installments of $100,000 by May 15, 2026.
- Resignation of two directors: Board members Justin Yorke and Robert Nistico resigned effective immediately in April 2026, creating near‑term changes in governance while the company addresses settlements and the disputed loan demand.
Insights
Settlement extensions and a disputed $2.8M loan demand highlight refinancing and liquidity pressure.
Splash Beverage has renegotiated settlements with prior investors, pushing remaining payments of $535,595 to June 1, 2026 at a relatively high 12% interest and covering investor legal fees. This suggests a need for near‑term flexibility but also increases financing costs.
The demand letter from Decathlon Alpha IV, L.P. claims obligations of $2,833,395.98 as of March 31, 2026, secured by company and subsidiary assets. Although the company disputes the default and is in discussions, the secured nature of the loan means any enforced remedy could affect operating assets and negotiating leverage.
Combined with previously delivered default notices in March 2025 and April 2025, this disputed demand underscores ongoing tension with the lender and the importance of whatever outcome emerges from negotiations or any subsequent legal process.
Two director resignations with a follow‑on consulting deal shift governance and incentives.
Directors Justin Yorke and Robert Nistico resigned from the board in late April 2026. Shortly after, Nistico signed a six‑month consulting agreement at $5,000 per month and will receive 250,000 stock options under the 2025 Equity Incentive Plan, subject to vesting triggers.
The first vesting condition requires the company to acquire Medterra CBD, LLC; if achieved, 125,000 options vest immediately and another 125,000 at the end of the consulting term, contingent on continued service. The agreement also schedules payment of $31,000 in previously owed expenses by June 30, 2026, aligning part of Nistico’s compensation with both an acquisition milestone and his ongoing involvement.